6 Results for "

LN-18

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "LN-18" in MCE Product Catalog:

Cat. No.: HY-176537
CAS No.: 3055038-20-2
Target:  

Microtubule/Tubulin

Research Areas:  

Cancer

RGN6024 is a brain-penetrant, orally active and reversible small molecule tubulin destabilizer. RGN6024 inhibits microtubule polymerization both in biochemical and cellular assays, binds to the colchicine binding pocket of β-tubulin (SPR: Kd = 6.7 μM; tryptophan assay: Kd = 7.4 μM), and triggers G2/M arrest in glioblastoma (GB) cells. RGN6024 retains activity in βIII-tubulin overexpressing cells. RGN6024 inhibits tumor growth in a GB xenograft mouse model. RGN6024 can be used for the study of glioblastoma (GB) .
loading...
    loading...
Cat. No.: HY-150791
CAS No.: 950665-12-0
Research Areas:  

Cancer

FLDP-5 is a blood-brain barrier (BBB) penetrant curcuminoid analogues. FLDP-5 can induce production of ROS (Reactive Oxygen Species), DNA damage and cell cycle S phase arrest. FLDP-5 exhibits highly potent tumour-suppressive effects with anti-proliferative and anti-migratory activities on LN-18 cells .
loading...
    loading...
Cat. No.: HY-150794
CAS No.: 861968-02-7
Target:  

Others

Research Areas:  

Cancer

FLDP-8 is a curcuminoid analogues, has potent anti-cancer effects. FLDP-8 can induce cell death with an IC50 value of 4 μM in LN-18 cells .
loading...
    loading...
Cat. No.: HY-165284
CAS No.: 1370652-56-4
Research Areas:  

Cancer

CM-118 is a potent and selective c-Met and ALK inhibitor. CM-118 inhibits the HGF-induced c-Met phosphorylation. CM-118 inhibits phosphorylation of ALK, EML4-ALKv1, ALK F1174L, and EMl4-ALKv1 L1196M, with respective IC50 values 0.92, 1.25, 1.9, and 3.5 μM. CM-118 exhibits anticancer activity against cancers dependent on the c-Met or ALK oncogenic pathways .
loading...
    loading...
Cat. No.: HY-18343
CAS No.: 259199-65-0
Target:  

MDM-2/p53 Apoptosis

Research Areas:  

Cancer

CP-31398 can stabilize the active conformation of p53 and promote p53 activity in cancer cells with either mutant or wild-type p53. In addition, CP-31398 can upregulate p53 target genes, such as p21WAF1/Cip1 and KILLER/DR5. CP-31398 exerts an inhibitory effect on tumor growth .
loading...
    loading...
Cat. No.: HY-186085
CAS No.: 3033961-38-2
Research Areas:  

Neurological Disease Cancer

BEN-28010 is a selective, orally active, blood-brain barrier permeable CHK1 inhibitor with an IC50 of 4.0 nM. BEN-28010 functions as a radiosensitizer, exhibits antitumor efficacy in GBM models. BEN-28010 can be used for the research of glioblastoma .
loading...
    loading...